Listed

CVS HEALTH Corp: Form 10-Q for the period ended Jun 30, 2013

Filed with the SEC on Aug 6, 2013 and accepted by EDGAR at Aug 6, 2013, 16:36 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2013-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2013-04-01 to 2013-06-30$31.25bnus-gaap:Revenues
Revenue6 months2013-01-01 to 2013-06-30$62.01bnus-gaap:Revenues
Cost of revenue3 months2013-04-01 to 2013-06-30$25.41bnus-gaap:CostOfRevenue
Cost of revenue6 months2013-01-01 to 2013-06-30$50.59bnus-gaap:CostOfRevenue
Gross profit3 months2013-04-01 to 2013-06-30$5.84bnus-gaap:GrossProfit
Gross profit6 months2013-01-01 to 2013-06-30$11.42bnus-gaap:GrossProfit
Operating income3 months2013-04-01 to 2013-06-30$1.97bnus-gaap:OperatingIncomeLoss
Operating income6 months2013-01-01 to 2013-06-30$3.67bnus-gaap:OperatingIncomeLoss
Interest expense3 months2013-04-01 to 2013-06-30$127.0mus-gaap:InterestExpense
Interest expense6 months2013-01-01 to 2013-06-30$254.0mus-gaap:InterestExpense
Income tax3 months2013-04-01 to 2013-06-30$720.0mus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2013-01-01 to 2013-06-30$1.34bnus-gaap:IncomeTaxExpenseBenefit
Net income3 months2013-04-01 to 2013-06-30$1.12bnus-gaap:ProfitLoss
Net income6 months2013-01-01 to 2013-06-30$2.08bnus-gaap:ProfitLoss
Diluted EPS3 months2013-04-01 to 2013-06-30$0.91us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2013-01-01 to 2013-06-30$1.68us-gaap:EarningsPerShareDiluted
Basic EPS3 months2013-04-01 to 2013-06-30$0.91us-gaap:EarningsPerShareBasic
Basic EPS6 months2013-01-01 to 2013-06-30$1.69us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2013-04-01 to 2013-06-301,236,000,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2013-01-01 to 2013-06-301,238,000,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2013-01-01 to 2013-06-30$2.54bnus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2013-01-01 to 2013-06-30$804.0mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid6 months2013-01-01 to 2013-06-30$553.0mus-gaap:PaymentsOfDividends
Share repurchases6 months2013-01-01 to 2013-06-30$748.0mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2013-06-30$1.17bnus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2013-06-30$19.87bnus-gaap:AssetsCurrent
Total assetsAt period end2013-06-30$66.28bnus-gaap:Assets
Current liabilitiesAt period end2013-06-30$12.69bnus-gaap:LiabilitiesCurrent
Long-term debtAt period end2013-06-30$9.36bnus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2013-06-30$18.0mus-gaap:LongTermDebtCurrent
Short-term borrowingsAt period end2013-06-30$0us-gaap:ShortTermBorrowings
Shareholders' equityAt period end2013-06-30$38.91bnus-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

Source: SEC EDGAR, the filing index for accession 0000064803-13-000021. Last ingested by Listed: Nov 6, 2026, 17:47 ET. Listed shows no prices and gives no investment advice.